Program Launch Specialist- Florida (future opportunity)
Procept BioRobotics
Summary
The Program Launch Specialist drives rapid referral activation, early utilization growth, and procedural conversion at newly launched Aquablation Therapy sites. The Program Launch Specialist acts as an extension of the regional commercial team during the first 90–120 days of new program launches — working through RSRs/ASRs to train office staff, optimize referral pathways, and ensure operational readiness. The Program Launch Specialist supports the core team without replacing their role, driving early adoption and sustainable patient flow.
Job description
The Opportunity That Awaits You
The Program Launch Specialist drives rapid referral activation, early utilization growth, and procedural conversion at newly launched Aquablation Therapy sites. The Program Launch Specialist acts as an extension of the regional commercial team during the first 90–120 days of new program launches — working through RSRs/ASRs to train office staff, optimize referral pathways, and ensure operational readiness. The Program Launch Specialist supports the core team without replacing their role, driving early adoption and sustainable patient flow.
What Your Day-To-Day Will Involve
- Partner with RSR/ASR to activate Aquablation patient pathways post-launch.
- Support Procedure Activation Success in Office and Hospital.
- Activate the referral funnel to convert BPH treatments aligned with the physician’s treatment algorithm and selection criteria.
- Activate the operational function of Aquablation Days in the Hospital with Revenue Cycle and OR Block.
- Train office staff on patient identification, scheduling, and referral flow.
- Collaborate with schedulers and administrators on billing, coding, and pre-authorization readiness.
- Train offices on operational and financial efficiencies to support adoption.
- Support surgeon champion development and conversion of respective procedures to Aquablation.
- Coordinate with Marketing and Reimbursement to deploy patient and staff education tools.
- Track patient flow, conversion rates, and reimbursement turnaround times.
Performance Metrics
- Referral and conversion rate growth.
- Case volume in first 90 days post-launch.
- Efficiency to first 10 procedures within 60 days of PO.
- Aquablation days measured by 4-6 procedures per day.
- Patient pathway activation efficiency.
- Reimbursement cycle time and billing accuracy.
- Stakeholder satisfaction and readiness.
The Qualifications We Need You to Possess
- Bachelor’s degree required; MBA preferred.
- 5–12 years in medical device sales, market development, or commercial operations (urology preferred).
- Strong understanding of referral dynamics, reimbursement, and hospital workflows.
- Proven ability to influence physician and office adoption.
- Analytical, data-driven mindset with strong collaboration skills.
- Willingness to travel up to 60%.
Requirements
- Bachelor’s degree required
- MBA preferred
- 5–12 years in medical device sales, market development, or commercial operations
- Urology experience preferred
- Strong understanding of referral dynamics, reimbursement, and hospital workflows
- Proven ability to influence physician and office adoption
- Analytical, data-driven mindset with strong collaboration skills
- Willingness to travel up to 60%
Company overview
PROCEPT BioRobotics is a pioneering surgical robotics company specializing in transformative urological solutions. Founded in 2009 and headquartered in San Jose, California, the company has established itself as a leader in robotic-assisted surgical technology. PROCEPT BioRobotics develops, manufactures, and markets the AQUABEAM® and HYDROS™ Robotic Systems, which deliver Aquablation therapy - the first FDA-cleared, image-guided, heat-free robotic therapy for urology. The company's primary focus is on treating benign prostatic hyperplasia (BPH), a condition affecting approximately 40 million men in the United States. Aquablation therapy represents a significant advancement in minimally invasive surgery, using a precise waterjet to remove prostate tissue while protecting surrounding nerves and structures that control sexual function. With over 150 peer-reviewed publications supporting its clinical evidence, PROCEPT BioRobotics has built a substantial body of research demonstrating the safety, efficacy, and durability of its technology. The company operates globally, with the majority of its revenue generated in the United States, and continues to expand its presence in international markets. As a publicly traded company (NASDAQ: PRCT), PROCEPT BioRobotics maintains a workforce of 501-1,000 employees dedicated to advancing robotic surgery and improving patient outcomes in urological care.